Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs)

Seizure

Volumn 23, Issue 5, 2014, Pages 371-376

  Stepanova, Daria ^a   Beran, Roy G ^a,b,c  

^a Strategic Health Evaluators   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Drug interaction; Epilepsy; Levetiracetam; Therapeutic monitoring

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; HARKOSERIDE; LAMOTRIGINE; VALPROIC ACID; ANTICONVULSIVE AGENT; PIRACETAM;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INTERACTION; DRUG MONITORING; EPILEPSY; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PEOPLE WITH EPILEPSY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEIZURE; SOLID PHASE EXTRACTION; ANALOGS AND DERIVATIVES; DOSE RESPONSE; DRUG COMBINATION; MIDDLE AGED; PROCEDURES; SEIZURES; YOUNG ADULT;

ADULT; AGED; ANTICONVULSANTS; CARBAMAZEPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PIRACETAM; SEIZURES; VALPROIC ACID; YOUNG ADULT;

EID: 84899647129     PISSN: 10591311     EISSN: 15322688     Source Type: Journal    
DOI: 10.1016/j.seizure.2014.02.003     Document Type: Article

References (29)

1. K.A. Lyseng-Williamson Spotlight on levetiracetam in epilepsy CNS Drugs 25 1 2011 901 905
2. A. DasGupta Therapeutic Drug Monitoring: Newer Drugs and Biomarkers 1st ed. 2012 Elsevier USA
3. P.N. Patsalos Pharmacokinetic profile of levetiracetam: toward ideal characteristics Pharmacol Ther 85 2 2000 77 85
4. C. Johannessen Landmark, and P.N. Patsalos Drug interactions involving the new second- and third-generation antiepileptic drugs Expert Rev Neurother 10 1 2010 119 140
5. T.R. Henry, and J.M. Conway Antiepilepsy drugs: mechanisms of action and pharmacokinetics Epilepsy Board Rev Man 1 5 2012 1 11
6. J.L. DeWolfe, and J.P. Szaflarski Levetiracetam use in the critical care setting Front Neurol 4 2013 1 8
7. S.I. Johannessen, and C. Johannessen Landmark Antiepileptic drug interactions - principles and clinical implications Curr Neuropharmacol 8 3 2010 254 267
8. M.D. Krasowski Therapeutic drug monitoring of the newer anti-epilepsy medications Pharmaceuticals 3 2010 1909 1935
9. L.J. Hirsch, H. Arif, R. Buchsbaum, D. Weintraub, J. Lee, and J.T. Chang et al. Effect of age and co-medication on levetiracetam pharmacokinetics and tolerability Epilepsia 48 7 2007 1351 1359
10. T. Tomson, R. Palm, K. Källén, E. Ben-Menachem, B. Söderfeldt, and B. Danielsson et al. Pharmacokinetics of levetiracetam during pregnancy, delivery in the neonatal period, and lactation Epilepsia 48 6 2007 1111 1116
11. M. Baulac, M.J. Brodie, C.E. Elger, K. Krakow, A. Stockis, and P. Meyvisch et al. Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures Epilepsia 48 3 2007 589 592
12. P.N. Patsalos, D.J. Berry, B.F.D. Bourgeois, J.C. Cloyd, T.A. Glauser, and S.I. Johannessen et al. Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies Epilepsia 49 7 2008 1239 1276
13. UCB Pharma, Inc. Data On File, Smyrna, GA 2001
14. R. Weber Ars Medici 21 2000 1289 1291
15. M. Schulz, and A. Schmoldt Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics Pharmazie 58 2003 447 474
16. Douglass Hanly Moir Macquarie Park Laboratory Method Summary 2013
17. Sonic Healthcare Integra TDM: Free Drug Levels method 2005
18. SSWPS Handbook - Lamotrigine: Serum/Plasma 2013
19. E. Faught Pharmacokinetic considerations in prescribing antiepileptic drugs Epilepsia 42 Suppl. 4 2001 19 23
20. K. Chan, and R.G. Beran Value of therapeutic drug level monitoring and unbound (free) levels Seizure 17 6 2008 572 575
21. B.J. Steinhoff, E.R. Somerville, W. Van Paesschen, P. Ryvlin, and I. Schelstraete The SKATE™ study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy Epilepsy Res 76 1 2007 6 14
22. L.J. Stephen, K. Kelly, P. Parker, and M.J. Brodie Levetiracetam monotherapy - outcomes from an epilepsy clinic Seizure 20 7 2011 554 557
23. B. Abou-Khalil Levetiracetam in the treatment of epilepsy Neuropsychiatr Dis Treat 4 3 2008 507 523
24. T. De Smedt, R. Raedt, K. Vonck, and P. Boon Levetiracetam. Part II. The clinical profile of a novel anticonvulsant drug CNS Drug Rev 13 1 2007 57 78
25. B.W.Y. Lo, H.H. Kyu, D. Jichici, A.M. Upton, E.A. Akl, and M.O. Meade Meta-analysis of randomized trials on first line and adjunctive levetiracetam Can J Neurol Sci 38 3 2011 475 486
26. E. Ben-Menachem, and U. Falter Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy Epilepsia 41 2000 1276 1283
27. B. Korby, P.E. Penovich, J.R. Gates, D.L. Dickens, and G.L. Moriarty Levetiracetam monotherapy Epilepsia 9 2003 1 7
28. B. Medhi, P.K. Singh, A. Prakash, and P. Avti Effect of esomeprazole on the pharmacokinetics of carbamazepine Indian J Pharmacol 43 1 2011 73 75
29. G.F. Mattson, R.H. Mattson, and J.A. Cramer Interaction between valproic acid and carbamazepine: an in vitro study of protein binding Ther Drug Monit 4 2 1982 181 184